New patent for the drug Glaxosmithkline ARNUITY ELLIPTA – DrugPatentWatch
Annual Drug Patent Expiration for ARNUITY+ELLIPTA
Arnuity Ellipta is a drug marketed by Glaxosmithkline and included in one NDA. It is available from a single supplier. There are six patents protecting this drug.
ARNUITY ELLIPTA drug price trends.
Drug patent litigation for ARNUITY ELLIPTA.
This drug has one hundred and two patent family members in twenty seven countries.
The generic ingredient in ARNUITY ELLIPTA is fluticasone furoate. One registered supplier for this compound. Additional details are available on the fluticasone furoate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug Glaxosmithkline ARNUITY ELLIPTA
